SBC Medical Group Holdings Inc
About SBC Medical Group Holdings Inc
SBC Medical Group Holdings Inc is a management company that provides management services to cosmetic treatment centers mainly in Japan. It is focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale). The firm generates revenue mostly from these management services.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $173.6M
- Net income
- $51.0M
- Total assets
- $380.4M
- Market cap
- $308.8M
- Gross margin
- 73.3%
- Operating margin
- 38.9%
- Net margin
- 29.4%
Source: SEC EDGAR · updated Jun 8, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $173.6M
- Cost of revenue
- $46.3M
- Gross profit
- $127.3M
- Operating expenses
- $59.8M
- Operating income
- $67.5M
- Income tax
- $31.0M
- Net income
- $51.0M
- EPS (basic)
- $0.50
- EPS (diluted)
- $0.50
Balance sheet
- Total assets
- $380.4M
- Current assets
- $231.2M
- Total liabilities
- $117.1M
- Current liabilities
- $61.1M
- Shareholders’ equity
- $263.3M
Cash flow
- Operating cash flow
- $24.7M
- Investing cash flow
- -$21.0M
- Financing cash flow
- $38.3M
- Net cash flow
- $42.0M
Statements via Polygon.io (SEC filings)
- Market cap
- $308.8M
- P/E ratio
- 5.9
- EPS (diluted)
- $0.5
- Dividend yield
- 58.11%
- Shares outstanding
- 104.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 18, 2024
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $51.0M in FY2025.
- Revenue declined 15% from FY2024 to FY2025.
- Gross margin of 73.3%, net margin 29.4%.
- Trading 48% below its 52-week high.
- Pays a dividend yielding about 58.11% annually.
- Valued at a price-to-earnings (P/E) ratio of 5.9.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review SBC Medical Group Holdings Inc.
Write a review
News about SBC Medical Group Holdings Inc
News & sentiment via Polygon.io
